Table 1 IC50 values of flavonols on BCRP activity.

From: Inhibition of breast cancer resistance protein by flavonols: in vitro, in vivo, and in silico implications of the interactions

Compound no.

Name

IC50 (µM)

-

Novobiocin

1.43

4

3,3’-Dihydroxyflavone

5.61

7

3,7-Dihydroxyflavone

3.14

8

3,7,3’-Trihydroxyflavone

2.78

17

3,6-Dihydroxyflavone

6.73

26

3,5,7-Trihydroxyflavone (galangin)

5.40

27

3,5,7,3’,4’-Pentahydroxyflavone (quercetin)

2.63

29

3,5,7,4’-Tetrahydroxy-3’-methoxyflavone (isorhamnetin)

3.50

31

3,5,7,2’,4’-Pentahydroxyflavone (morin)

24.9

32

3,5,7,3’,4’-Pentahydroxy-8-methylflavone

2.91

37

3,4’-Dimethoxyflavone

1.62

39

3,3’,4’-Trimethoxyflavone

3.79

43

4’-Hydroxy-3,7,3’-trimethoxyflavone

2.31

44

3,6-Dimethoxyflavone

8.20

45

3,6,3’-Trimethoxyflavone

8.98

46

3,6,3’,4’-Tetramethoxyflavone

1.69

47

3,6,2’,3’-Tetramethoxyflavone

15.5

48

5,7,3’-Trihydroxy-3,4’-dimethoxyflavone

3.54

50

5-Hydroxy-3,7,3’,4’-tetramethoxyflavone (retusin)

2.23

51

3,5,7-Trimethoxyflavone

7.06

52

6,3’-Dihydroxy-3,5,7,4’-tetramethoxyflavone

3.62

53

3,5,6,7,4’-Pentamethoxyflavone

3.62

54

3,5,6,7,3’,4’-Hexamethoxyflavone

2.81